64 related articles for article (PubMed ID: 7417025)
1. [Relationship between the structure and clinical course of chondrosarcomas].
Ivanenko SN
Arkh Patol; 1980; 42(7):63-7. PubMed ID: 7417025
[TBL] [Abstract][Full Text] [Related]
2. [Clinico-morphological characteristics of bone chondrosarcomas].
Petrovichev NN; Eremina LA; Kasumov NV
Vopr Onkol; 1984; 30(4):14-20. PubMed ID: 6730402
[TBL] [Abstract][Full Text] [Related]
3. [Chondrosarcoma secondary to multiple cartilage diseases. Study of 29 clinical cases and review of the literature].
Schaison F; Anract P; Coste F; De Pinieux G; Forest M; Tomeno B
Rev Chir Orthop Reparatrice Appar Mot; 1999 Dec; 85(8):834-45. PubMed ID: 10637885
[TBL] [Abstract][Full Text] [Related]
4. The prognostic significance of nuclear DNA content in chondrosarcoma.
Kreicbergs A; Zetterberg A; Söderberg G
Anal Quant Cytol; 1980 Dec; 2(4):272-9. PubMed ID: 7469202
[TBL] [Abstract][Full Text] [Related]
5. [Poorly differentiated ("dedifferentiated") chondrosarcoma].
Petrovichev NN; Eremina LA; Khmelev LA; Kasumov NV
Vopr Onkol; 1984; 30(1):8-13. PubMed ID: 6695530
[TBL] [Abstract][Full Text] [Related]
6. Survival analysis of patients with chondrosarcomas of the pelvis.
Mavrogenis AF; Angelini A; Drago G; Merlino B; Ruggieri P
J Surg Oncol; 2013 Jul; 108(1):19-27. PubMed ID: 23681650
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic significance of p53, HER-2/neu, Ki-67 and VEGF expression in chondrosarcomas].
Stepanova EV; Kharatishvili TK; Lichinitser MR; Baryshnikov AIu; Solov'ev IuN; Trapeznikov NN
Arkh Patol; 2002; 64(6):9-12. PubMed ID: 12534219
[TBL] [Abstract][Full Text] [Related]
8. H-ras oncogene mutation in dedifferentiated chondrosarcoma: polymerase chain reaction-restriction fragment length polymorphism analysis.
Sakamoto A; Oda Y; Adachi T; Oshiro Y; Tamiya S; Tanaka K; Matsuda S; Iwamoto Y; Tsuneyoshi M
Mod Pathol; 2001 Apr; 14(4):343-9. PubMed ID: 11301351
[TBL] [Abstract][Full Text] [Related]
9. Imaging of chondrosarcoma with histopathological and prognostic correlation. An analysis of 49 cases mainly based on plain film radiography.
Jurik AG; Jensen O; Keller J; Nielsen OS; Lundorf E; Daugaard S; Sneppen O
Rofo; 1995 Nov; 163(5):372-7. PubMed ID: 8527748
[TBL] [Abstract][Full Text] [Related]
10. [Malignant chondroblastoma of bone (variants in its structure and histological diagnosis)].
Lipkin SI
Arkh Patol; 1995; 57(1):23-7. PubMed ID: 7771925
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of cytofluorometric DNA ploidy analysis in distinguishing benign cartilaginous tumors from chondrosarcomas.
Kusuzaki K; Murata H; Takeshita H; Hirata M; Hashiguchi S; Tsuji Y; Nakamura S; Ashihara T; Hirasawa Y
Mod Pathol; 1999 Sep; 12(9):863-72. PubMed ID: 10496594
[TBL] [Abstract][Full Text] [Related]
12. Grade 2 chondrosarcoma: stage I or stage II tumor?
Reith JD; Horodyski MB; Scarborough MT
Clin Orthop Relat Res; 2003 Oct; (415):45-51. PubMed ID: 14612628
[TBL] [Abstract][Full Text] [Related]
13. Prognostic relevance of cell biologic and biochemical features in conventional chondrosarcomas.
Aigner T; Müller S; Neureiter D; Illstrup DM; Kirchner T; Björnsson J
Cancer; 2002 Apr; 94(8):2273-81. PubMed ID: 12001127
[TBL] [Abstract][Full Text] [Related]
14. Minichromosome maintenance protein (MCM6) in low-grade chondrosarcoma: distinction from enchondroma and identification of progressive tumors.
Helfenstein A; Frahm SO; Krams M; Drescher W; Parwaresch R; Hassenpflug J
Am J Clin Pathol; 2004 Dec; 122(6):912-8. PubMed ID: 15539383
[TBL] [Abstract][Full Text] [Related]
15. Chondrosarcoma of bone: analysis of 108 cases and evaluation for predictors of outcome.
Rizzo M; Ghert MA; Harrelson JM; Scully SP
Clin Orthop Relat Res; 2001 Oct; (391):224-33. PubMed ID: 11603673
[TBL] [Abstract][Full Text] [Related]
16. Malignant transformation in human chondrosarcoma cells supported by telomerase activation and tumor suppressor inactivation.
Martin JA; Forest E; Block JA; Klingelhutz AJ; Whited B; Gitelis S; Wilkey A; Buckwalter JA
Cell Growth Differ; 2002 Sep; 13(9):397-407. PubMed ID: 12354749
[TBL] [Abstract][Full Text] [Related]
17. Absence of IHH and retention of PTHrP signalling in enchondromas and central chondrosarcomas.
Rozeman LB; Hameetman L; Cleton-Jansen AM; Taminiau AH; Hogendoorn PC; Bovée JV
J Pathol; 2005 Mar; 205(4):476-82. PubMed ID: 15685701
[TBL] [Abstract][Full Text] [Related]
18. Combination of microsurgery and Gamma Knife surgery for the treatment of intracranial chondrosarcomas.
Förander P; Rähn T; Kihlström L; Ulfarsson E; Mathiesen T
J Neurosurg; 2006 Dec; 105 Suppl():18-25. PubMed ID: 18503325
[TBL] [Abstract][Full Text] [Related]
19. [Calmodulin level in chondrosarcomas].
Kushlinskiĭ NE; Solov'ev IuN; Galkina NM; Aliev MD; Kharatishvili TK; Babkina NV; Berezov TT; Trapeznikov NN
Biull Eksp Biol Med; 2000 Feb; 129(2):198-200. PubMed ID: 10732246
[No Abstract] [Full Text] [Related]
20. [Interstitial substance of a chondrosarcoma (a histochemical study].
Ivanenko SN
Arkh Patol; 1980; 42(10):14-7. PubMed ID: 6449919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
